Trial intelligence / Profile preview

Effect of COX-2 Selective Inhibitors on Postoperative Insulin Resistance, Tramadol PCA and Early Postoperative Enteral Nutrition in Patients After Gastrointestinal Laparoscopic Surgery

NCT01930318Phase 4Unknown

Sponsor
Jinling Hospital
Start
Aug 2013
Primary completion
Aug 2015
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of parecoxib, celecoxib oral solution in postoperative pain, insulin resistance (IR), sponsored by Jinling Hospital. Status: unknown.

02

Drugs

parecoxibcelecoxib oral solution
03

Conditions

postoperative paininsulin resistance (IR)

Beyond the preview

Go deeper on NCT01930318.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01930318.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call